Neuroscience Education Institute

Today on World Schizophrenia Day, NEI joins the global effort to raise awareness, promote understanding, and help reduce stigma surrounding schizophrenia.

We remain committed to supporting mental health professionals with evidence-based education and practical resources that improve patient care and outcomes. Explore expert insights, clinical tools, and educational resources designed to support the assessment, diagnosis, and management of schizophrenia. View resources 👉

World Schizophrenia Day: Education & Resources World Schizophrenia Day is observed each year on May 24 to raise awareness of schizophrenia, promote understanding, and help reduce stigma surrounding this complex mental health condition.

Thank you to everyone who stopped by the NEI Booth at the 2026 APA Annual Meeting in San Francisco! It was a pleasure connecting with so many passionate mental health professionals and having meaningful conversations about the future of psychiatric care.

We are inspired by the dedication of this community and grateful for the opportunity to share how NEI is helping shape the future of mental health treatment and education. We look forward to continuing the conversation and supporting you througho ut your professional journey.

Get a first look at the sessions and topics shaping this year’s NEI Fall Congress. Talk titles are now live. Start exploring the ideas and conversations coming to the stage. 👀

Get a First Look at NEI Fall Congress Sessions Get a first look at the sessions and topics shaping this year’s NEI Fall Congress. Talk titles are now live. Start exploring the ideas and conversations coming to the stage.

Children’s Mental Health Awareness Day highlights the importance of recognizing and addressing the mental health needs of children and adolescents because early support can change lives.

NEI is committed to empowering the clinicians who care for young patients with mental health disorders. We continue to expand our resources to provide practical tools, expert education, and evidence-based guidance for pediatric care.

Explore what’s available to support your practice:
• Child & Adolescent Psychiatry Academy | November 4, 2026
• NEI Prescribe app with a dedicated Child & Adolescent section
• Encore presentations featuring evidence-based therapeutic strategies
• Clinical Toolkit with treatment algorithms for ADHD, Anxiety, Bipolar Disorder, Insomnia, MDD, and OCD
• and much more, visit https://nei.global/21163

Together, we can strengthen care and improve outcomes for children and young people!

Children’s Mental Health Awareness Day | Supporting Clinicians Who Care for Young Minds Children’s Mental Health Awareness Day highlights the importance of recognizing and addressing the mental health needs of children and adolescents because early support can change lives.

A new network meta-analysis in JAMA Psychiatry by Drs. Roger S. McIntyre, Stephen M. Stahl, and colleagues evaluates 22 randomized controlled trials comparing five FDA-approved adjunctive antipsychotics for adults with MDD and inadequate antidepressant response. For the first time, a Bayesian approach establishes a clear hierarchy of efficacy and acceptability, offering actionable insights for treatment selection. Read more

Choosing an Adjunctive Antipsychotic for Major Depressive Disorder: What a New Network Meta-Analysis Tells Us Article at a Glance A network meta-analysis (NMA) from Roger S. McIntyre, Stephen M. Stahl, and colleagues, published in JAMA Psychiatry, synthesizes 22 randomized controlled trials (N = 10,962) comparing five FDA-approved adjunctive antipsychotics — aripiprazole, brexpiprazole, cariprazine, queti...

This National Nurses Week, NEI is honored to recognize the nurses whose dedication and expertise elevate patient care every day.

Your dedication to your patients and the healthcare community motivates us to continue building education designed to support your work and professional growth.

In this episode, Dr. Andy Cutler sits down with Dr. Neill Epperson to break down how to assess cognitive complaints in women. They explore how to distinguish between ADHD, hormonal shifts like perimenopause, mood and anxiety disorders, and normal age-related changes.

Episode 281 - ADHD, Hormones, or Aging? Sorting Out Cognitive Complaints in Women with Dr. Neill Epperson In this episode, Dr. Andy Cutler speaks with Dr. Neill Epperson about how to evaluate cognitive complaints in women. They discuss how to differentiate between ADHD, hormonal changes (such as perimenopause), mood and anxiety disorders, and age-related cognitive decline. The conversation highlights ke...